Camlin Fine Sciences Postpones Filing of OPAS for Vinpai Shares, No Squeeze-Out Procedure Intended

Camlin Fine Sciences Ltd. (CFSL) has announced that it will postpone the filing of a simplified cash tender offer (OPAS) for the remaining shares of Vinpai, a French société anonyme, until early May 2026. The decision is due to administrative constraints related to Indian foreign exchange regulations and the proximity of Vinpai's 2025 annual financial statements publication. CFSL also announced that it no longer intends to implement a squeeze-out procedure for Vinpai shares from the Euronext Growth Paris market, as maintaining the listing will allow Vinpai to retain market visibility and have access to financial markets. This decision supports the financing of CFSL's future projects in Europe.